The virologic, immunologic, and clinical effects of interleukin 2 with potent antiretroviral therapy in patients with moderately advanced human immunodeficiency virus infection. A randomized controlled clinical trial - AIDS clinical trials group 328
Ronald Mitsuyasu, Rebecca Gelman, Deborah Weng Cherng, Alan Landay, John Fahey, Richard Reichman, Alejo Erice, R. Pat Bucy, J. Michael Kilby, Michael M. Lederman, Carol D. Hamilton, Juan Lertora, Becky L. White, Pablo Tebas, Anne Marie Duliege, Richard B. Pollard
Research output: Contribution to journal › Article › peer-review
Dive into the research topics of 'The virologic, immunologic, and clinical effects of interleukin 2 with potent antiretroviral therapy in patients with moderately advanced human immunodeficiency virus infection. A randomized controlled clinical trial - AIDS clinical trials group 328'. Together they form a unique fingerprint.